HEMOPHILIA TREATMENT MARKET ANALYSIS

Hemophilia Treatment Market, By Product Type (Plasma Derived Coagulation Factor, Recombinant Coagulation Factor, Antifibrinolytic Agents, and Desmopressin), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Mar 2023
Code : CMI2012
Pages :180
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Global Hemophilia Treatment Market: Restraint

Increasing number of product recalls by regulatory authorities

Regulatory authorities are recalling products due to mislabelling on the cartons. For instance, in November 2020, mislabeling on cartons of four lots of Tranexamic Acid Injection, USP 1000 mg/10 mL were packed in cartons of 10 single-dose 10 mL vials. Thus, U.S. Food and Drug Administration recalled Tranexamic acid injection manufactured by Mylan, a generic and speciality pharmaceutical company. Hence, increasing number of product recalls is likely to hinder the market growth.